BIO-B

Bio-Rad Laboratories, Inc. Class B

$304.15 +13.73%

Share classes & related securities

BIO-B is the same company as:

BIO · primary

Recent alerts on BIO-B

All signals →

News S&P 500 Shake-Up: New Entrants Driving Market Momentum

News Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

News Stock Market Today: Apple Earnings Power S&P 500, Nasdaq To Records; Trump Hits EU

News Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption

News Bio-Rad outlines 2026 margin expansion and 0.5%-1.5% revenue growth guidance amid operational improvements

News Qiagen Explores Possible Sale After New Buyer Talks: Report

News Antibody Optimization Service (Affinity Maturation, Humanization, Phage Display, AI-based Computational Optimization) Market Trends Analysis and Growth Forecast Report 2025-2033

News Custom Antibody Market to Reach USD 1,297.65 Million by 2033, Growing Demand for Precision Medicine and Targeted Therapies to Drive the Market – SNS Insider

Get push alerts for BIO-B

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS